Questions raised here may be answered by evaluating the effects of PDE9A inhibitors in atherosclerotic cardiovascular disease, which may outline future directions to better understand pathological changes and may contribute to expand opportunities in drug development in the field of atherosclerosis-related disorders. The gene discussed is PDE9A; the disease is atherosclerosis.